After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Vera Therapeutics Inc is $1.44B. A total of 2.66 million shares were traded on the day, compared to an average of 1.77M shares.
In the most recent transaction, ENRIGHT PATRICK G bought 209,393 shares of VERA for 20.87 per share on Jun 23 ’25. After the transaction, the Director now owns 3,569,522 company shares. In a previous transaction on Jun 24 ’25, ENRIGHT PATRICK G bought 40,607 shares at 22.35 per share. VERA shares that Director owns now total 3,596,593.
Among the insiders who sold shares, Fordyce Marshall disposed of 10,613 shares on Feb 21 ’25 at a per-share price of $27.89. This resulted in the PRESIDENT AND CEO holding 213,740 shares of VERA after the transaction. In another insider transaction, Fordyce Marshall sold 9,075 shares at $27.65 per share on Feb 26 ’25. Company shares held by the PRESIDENT AND CEO now total 204,665.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VERA has a high of $51.61 and a low of $18.53.
As of this writing, VERA has an earnings estimate of -$0.62 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.69 per share and a lower estimate of -$0.9.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VERA’s latest balance sheet shows that the firm has $79.67M in Cash & Short Term Investments as of fiscal 2021. There were $4.92M in debt and $7.69M in liabilities at the time. Its Book Value Per Share was $8.39, while its Total Shareholder’s Equity was $69.59M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERA is Buy with a score of 4.86.
